机构

• 上海药物研究所 [78]
• 自动化研究所 [3]
• 生态环境研究中心 [3]
• 过程工程研究所 [2]
• 近代物理研究所 [2]
• 深圳先进技术研究院 [1]
• 更多

采集方式

• OAI收割 [91]
• iSwitch采集 [2]

内容类型

• 期刊论文 [90]
• 会议论文 [3]

发表日期

• 2024 [2]
• 2023 [12]
• 2022 [4]
• 2021 [5]
• 2020 [9]
• 2019 [4]
• 更多

学科主题

筛选

浏览/检索结果: 共93条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 A novel pterostilbene compound DCZ0825 induces macrophage M1 differentiation and Th1 polarization to exert anti-myeloma and immunomodulatory 期刊论文  OAI收割 INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 卷号: 127, 页码: 14 作者:  Zhang, Hui;  Hu, Ke;  Lu, Yumeng;  Xu, Zhijian;  Chen, Gege   |  收藏  |  浏览/下载：9/0  |  提交时间：2024/03/25 Multiple myeloma  M1 macrophages  Th1 cells  Immunomodulatory   Dimeric cation-cation aggregates stabilized by 2Ch-2N chalcogen bonds: Crystallographic and theoretical evidences 期刊论文  OAI收割 CHEMICAL PHYSICS, 2024, 卷号: 576, 页码: 10 作者:  Liu, Na;  Han, Zijian;  Lu, Yunxiang;  Xu, Zhijian;  Zhu, Weiliang   |  收藏  |  浏览/下载：6/0  |  提交时间：2023/12/11 2Ch-2N chalcogen bonds  Homocations  Solvents  Evidences   Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cells 期刊论文  OAI收割 INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 卷号: 125, 页码: 15 作者:  Feng, Qilin;  Hu, Ke;  Hu, Huifang;  Lu, Yumeng;  Zhang, Hui   |  收藏  |  浏览/下载：24/0  |  提交时间：2024/01/16 DLBCL  ROS  DNA damage  JNK  Mitochondrial dysfunction   Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation 期刊论文  OAI收割 ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2023, 卷号: 55, 期号: 12, 页码: 1884-1891 作者:  Jin, Shuhan;  Li, Bo;  Zhang, Bibo;  Gao, Xuejie;  Jia, Xinyan   |  收藏  |  浏览/下载：8/0  |  提交时间：2024/02/27 dihydrocelastrol  multiple myeloma  JAK2/STAT3  PSMB5  bortezomib resistance   The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway 期刊论文  OAI收割 JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 卷号: 21, 期号: 1, 页码: 17 作者:  Wang, Yingcong;  Dong, Sanfeng;  Hu, Ke   |  收藏  |  浏览/下载：12/0  |  提交时间：2024/01/26 Norcantharidin  Derivative  DCZ5417  TRIP13  Anti-myeloma  MAPK   TI17, a novel compound, exerts anti-MM activity by impairing Trip13 function of DSBs repair and enhancing DNA damage 期刊论文  OAI收割 CANCER MEDICINE, 2023, 页码: 14 作者:  Chang, Shuaikang;  Xiao, Wenqin;  Xie, Yongsheng;  Xu, Zhijian;  Li, Bo   |  收藏  |  浏览/下载：7/0  |  提交时间：2023/12/11 DNA damage  DSBs repair  myeloma  TI17  Trip13   Discovery of zolinium TSG1180 as a novel agonist of transgelin-2 for treating asthma 期刊论文  OAI收割 Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, 卷号: 167, 页码: 115556 作者:  Yuan, Hong-Kai;  Li, Bo;  Wu, Leyun;  Wang, Xue-Ling;  Lv, Zhi-Ying   |  收藏  |  浏览/下载：6/0  |  提交时间：2024/03/26 Active learning  Consensus labelling  Eye irritation  Serious eye damage  Structural alerts   Design, synthesis and biological evaluation of chalcone derivatives as potent and orally active hCYP3A4 inhibitors 期刊论文  OAI收割 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 卷号: 95, 页码: 9 作者:  Lu, Shiwei;  Zhang, Feng;  Gong, Jiahao;  Huang, Jian;  Zhu, Guanghao   |  收藏  |  浏览/下载：10/0  |  提交时间：2023/12/08 Cytochrome P450 3A4 (CYP3A4)  Inhibitors  Isoquinoline chalcones  Orally active   Attention Weighted Local Descriptors 期刊论文  OAI收割 IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE, 2023, 卷号: 45, 期号: 9, 页码: 10632-10649 作者:  Wang, Changwei;  Xu, Rongtao;  Lu, Ke;  Xu, Shibiao;  Meng, Weiliang   |  收藏  |  浏览/下载：5/0  |  提交时间：2023/11/17 Local features detection and description  consistent attention mechanism  context augmentation  lightweight local descriptors  knowledge distillation   ETCM v2.0: An update with comprehensive resource and rich annotations for traditional Chinese medicine 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 6, 页码: 2559-2571 作者:  Zhang, Yanqiong;  Li, Xin;  Shi, Yulong;  Chen, Tong;  Xu, Zhijian   |  收藏  |  浏览/下载：21/0  |  提交时间：2023/10/17 Traditional Chinese medicine  Database  Target identification  Network visualization  New drug research and development  Molecular mechanism  Quality marker  Drug repurposing